Prestige Biologics Co., Ltd. (KOSDAQ:334970)

South Korea · Delayed Price · Currency is KRW

1,408.00

+2.00 (0.14%)

At close: Oct 8, 2026

Prestige Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022
Market Capitalization	109,476	172,611	283,797	245,391	272,542	184,546
Market Cap Growth	-55.86%	-39.18%	15.65%	-9.96%	47.68%	-59.28%
Enterprise Value	203,839	257,039	364,568	378,645	369,331	283,846
Last Close Price	1408.00	2220.00	3650.00	3990.00	4460.00	3020.00

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022
PS Ratio	4.11	6.47	22.64	113.13	156.11	11855.95
PB Ratio	1.21	1.91	2.10	3.42	2.73	1.57
P/TBV Ratio	1.23	1.94	2.12	3.46	2.76	1.58
P/FCF Ratio	120.18	189.49	-	-	-	-
P/OCF Ratio	34.18	53.89	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022
EV/Sales Ratio	7.64	9.64	29.09	174.57	211.55	18235.34
EV/FCF Ratio	223.77	282.17	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	1.12	1.12	0.68	2.41	1.60	1.01
Debt / FCF Ratio	111.21	111.21	-	-	-	-
Net Debt / Equity Ratio	1.04	1.04	0.67	2.00	1.15	0.88
Net Debt / EBITDA Ratio	-2.91	-2.91	-4.36	-6.47	-3.62	-3.60
Net Debt / FCF Ratio	103.59	103.59	-3.82	-8.51	-1.90	-0.87
Asset Turnover	0.10	0.10	0.05	0.01	-	0
Inventory Turnover	1.69	1.69	1.28	0.89	-	0.00
Quick Ratio	0.08	0.08	0.06	0.34	0.53	0.54
Current Ratio	0.29	0.29	0.40	0.60	0.79	0.92
Return on Equity (ROE)	-45.40%	-45.40%	-26.55%	-34.26%	-	-44.30%
Return on Assets (ROA)	-11.48%	-11.48%	-7.52%	-7.02%	-	-9.85%
Return on Capital Employed (ROCE)	-43.20%	-43.20%	-20.10%	-17.00%	-18.50%	-16.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 7, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022
Earnings Yield	-46.79%	-29.67%	-9.68%	-11.97%	-14.47%	-26.94%
FCF Yield	0.83%	0.53%	-8.29%	-6.87%	-22.11%	-64.36%
Buyback Yield / Dilution	-5.54%	-5.54%	-20.22%	-4.43%	-13.35%	-16.43%